Serum proprotein convertase subtilisin/kexin 9 (PCSK9) is a monoclonal antibody that increases recycling of LDL receptors and is hypothesized to reduce LDL in circulation. According to clinical trial results in The New England Journal of Medicine, treatment with atorvastatin and PCSK9 showed effective...

Research published in The Archives in Pediatrics & Adolescent Medicine discusses whether “the degree of obesity predicts the efficacy of long-term behavioral treatment and to explore any interaction with age.” After conducting a three-year long study with 643 children across all ages,...

β-Blockers have long been prescribed as medication following a myocardial infarction (MI). However, new research published in The Journal of the American Medical Association investigated the use of β-Blockers in patients with coronary artery disease (CAD) but no history of MI, those with a remote...